Corvus Pharmaceuticals Inc. held its Annual Meeting of Stockholders on June 12, 2025. During the meeting, stockholders elected Ian T. Clark and Peter A. Thompson, M.D. to the Board of Directors. Additionally, the selection of PricewaterhouseCoopers LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Stockholders also approved, on a non-binding advisory basis, the compensation of the named executive officers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corvus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-003881), on June 13, 2025, and is solely responsible for the information contained therein.